FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

ViiV Wins Adolescent HIV Use for Dovato

FDA approves ViiV Healthcares Dovato (dolutegravir/lamivudine) for treating HIV-1 infection in adolescents with no antiretroviral treatment history or...

latest-news-card-1
Human Drugs

Stealth Bio NDA for Barth Syndrome Accepted

FDA accepts for review a Stealth BioTherapeutics NDA for elamipretide for treating Barth syndrome.

latest-news-card-1
Federal Register

Shuffert Debarred for 5 Years

Federal Register notice: FDA issues an order to debar for five years Robert Lance Shuffert from importing or offering for import any drug into the U.S...

latest-news-card-1
Human Drugs

Abecma Expanded Approval for Multiple Myeloma

FDA approves a Bristol Myers Squibb and 2Seventy Bio supplemental BLA for Abecma (idecabtagene vicleucel; ide-cel) for treating certain adult patients...

latest-news-card-1
Medical Devices

Honeywell Recalls Eyewash Cartridge

Honeywell Safety Products recalls its Fendall 2000 Non-Sterile Eyewash Cartridge for the Fendall 2000 Eyewash Station due to GMP concerns.

latest-news-card-1
Human Drugs

Accelerated Approval for Enhertu in Solid Tumors

FDA grants Daiichi Sankyo an accelerated approval for Enhertu (fam-trastuzumab deruxtecan-nxki) for treating certain adult patients with unresectable ...

latest-news-card-1
Human Drugs

Jubilant Generics Cited Over GMPs

FDA issues Jubilant Generics a four-observation Form FDA-483 after inspecting the firms India facility in February.

latest-news-card-1
Human Drugs

AbbVie Urges FDA to Ban Unlicensed Thyroid Products

AbbVie petitions FDA urging it to crack down on newly introduced unlicensed desiccated thyroid extract products.

latest-news-card-1
Federal Register

FDA Seeks Industry Rep for Device Panel

Federal Register notice: FDA seeks industry organizations interested in participating in selecting a nonvoting industry representative to serve on CDR...

latest-news-card-1
Federal Register

Panel to Discuss Pediatric Studies for Cancer Drugs

Federal Register notice: FDA announces a 5/22 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee meeting to discuss requirement...